Introduction: Basal cell carcinoma (BCC) is the most common non-melanoma skin cancer. The aim of the current study was to analyze the ultraviolet-enhanced fluorescence dermoscopy (UVFD) characteristics of BCCs. Methods: BCCs were evaluated under polarized dermoscopy (PD) and UVFD. The findings in PD were described using predefined parameters for dermoscopic evaluation in dermato-oncology. UVFD characteristics were determined based on personal observations, and included interrupted follicle pattern, absence of pink-orange or blue-green fluorescence, well-demarcated borders, and dark silhouettes. Results: In total, 163 BCCs were analyzed. Under UVFD, the interrupted follicle pattern (p< 0.001), absence of pink-orange fluorescence (p= 0.005) and well-demarcated borders (p= 0.031) were more frequently noted in BCCs < 5 mm than in bigger tumors. Lesions on the face showed clearly defined borders (p= 0.031) and interrupted follicle pattern (p< 0.001) more frequently than tumors located beyond the face. Nodular BCCs displayed interrupted follicle pattern (p= 0.001) and absence of pink-orange fluorescence (p< 0.001) more commonly than superficial subtypes. Non-pigmented BCCs more frequently showed lack of blue-green fluorescence (p= 0.007) and interrupted follicle pattern (p= 0.018) compared to pigmented variants. Conclusions: UVFD may be a valuable, complementary to PD, tool in the diagnosis of BCC, particularly in small tumors, lesions located on the face and nodular or non-pigmented subtypes.
引言:基底细胞癌(BCC)是最常见的非黑色素瘤皮肤癌。本研究旨在分析基底细胞癌在紫外增强荧光皮肤镜(UVFD)下的特征。方法:通过偏振光皮肤镜(PD)和UVFD对基底细胞癌进行评估。PD下的观察结果采用皮肤肿瘤学中皮肤镜评估的预设参数进行描述。UVFD特征基于个人观察确定,包括毛囊中断模式、粉橙色或蓝绿色荧光缺失、边界清晰以及暗色轮廓。结果:共分析了163例基底细胞癌。在UVFD下,直径小于5毫米的基底细胞癌比更大肿瘤更频繁地表现出毛囊中断模式(p<0.001)、粉橙色荧光缺失(p=0.005)和边界清晰(p=0.031)。面部病灶比非面部肿瘤更频繁地显示清晰边界(p=0.031)和毛囊中断模式(p<0.001)。结节型基底细胞癌比浅表亚型更常见毛囊中断模式(p=0.001)和粉橙色荧光缺失(p<0.001)。与非色素型相比,色素型基底细胞癌更频繁地显示蓝绿色荧光缺失(p=0.007)和毛囊中断模式(p=0.018)。结论:UVFD可能是一种有价值的、与PD互补的诊断基底细胞癌的工具,尤其适用于小肿瘤、面部病灶以及结节型或非色素型亚型。
Application of Ultraviolet-Enhanced Fluorescence Dermoscopy in Basal Cell Carcinoma